SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): December 20, 2005
OPHTHALMIC IMAGING SYSTEMS
------------------------------------------------------
(Exact name of registrant as specified in its charter)
CALIFORNIA 1-11140 94-3035367
---------- ------- ----------
State or other (Commission (I.R.S. Employer
jurisdiction of File Number) Identification No.)
incorporation)
221 Lathrop Way, Suite I
Sacramento, California 95815
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(Registrant's telephone number, including area code): (916) 646-2020
Not Applicable
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 7.01. REGULATION FD DISCLOSURE.
On December 20, 2005, Ophthalmic Imaging Systems (the "Registrant")
issued a press release announcing that MediVision Medical Imaging Ltd., its
major shareholder, sold 310,000 shares of the Registrant's common stock at $1.45
per share. A copy of the Registrant's press release is attached hereto as
Exhibit 99.1.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits
Exhibit Number Description
-------------- -----------
99.1 Press Release of the Registrant dated December 20, 2005.
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
as amended, the Registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
Date: December 21, 2005 OPHTHALMIC IMAGING SYSTEMS
By: /s/ Ariel Shenhar
-----------------------------
Name: Ariel Shenhar
Title: Chief Financial Officer